Home / Recalls / McKesson Corporation dba McKesson Drug Company / D-0630-2021

D-0630-2021 Class III Terminated

Recalled by McKesson Corporation dba McKesson Drug Company — Memphis, TN

Recall Details

Product Type
Drugs
Report Date
June 16, 2021
Initiation Date
May 26, 2021
Termination Date
September 29, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
210 cartons

Product Description

Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson Corporation 4971 Southridge Blvd., Suite 101 Memphis, TN 38141 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 090, India NDC 63739-795-10

Reason for Recall

Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam

Distribution Pattern

Nationwide in the US

Code Information

Lot: 0000124916 Exp. 09/30/2022

Other recalls by McKesson Corporation dba McKesson Drug Company

  • D-0850-2022 Class II — Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented) (Potency expressed a (April 21, 2022)
  • D-0848-2022 Class II — Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL bottle, Rx onl (April 21, 2022)
  • D-0851-2022 Class II — Erythromycin Topical Gel USP, 2%, Net Wt 60 g tube, Rx only, Manufactured by: Te (April 21, 2022)
  • D-0849-2022 Class II — Lidocaine Prilocaine Cream USP, 2.5%/2.5% Net Wt. 30 gram tube, Rx Only, Distrib (April 21, 2022)
  • D-0847-2022 Class II — Halobetasol Propionate Ointment 0.05% Net Wt., 50 gram tube, Rx Only, Manufactur (April 21, 2022)